Changes

Jump to navigation Jump to search
Line 109: Line 109:     
===Prostaglandin F2α===
 
===Prostaglandin F2α===
Prostaglanin is a C<sub>2</sub>O fatty acid and is produced within the uterine endometrium and vesicular glands. The target tissue in the female is the corpus luteum, uterine myometrium and ovulatory follicles. In the female prostaglandin can cause luteolysis and also cause the induction of tone and contractions within the uterus and ovulation.
+
Prostaglanin is a C<sub>2</sub>O fatty acid and is produced within the uterine endometrium and vesicular glands. Prostaglandins are lipid soluable and are therefore able to diffuse into the ovarian artery via veins that would otherwise take the PGF<sub>2α</sub> away from the uterine horn. The target tissue in the female is the corpus luteum, uterine myometrium and ovulatory follicles. In the female prostaglandin can cause luteolysis and also cause the induction of tone and contractions within the uterus and ovulation.
 
<br />
 
<br />
 
<br />
 
<br />
During the latter stages of the luteal phase the corpus luteum begins to regress under the effect of PGF<sub>2α</sub>. Normally the concentrations of PGF<sub>2α</sub> in arterial blood is relatively low due to extensive metabolism via the lungs. However there is a large concentration gradient from the uterine vein to the ovarian artery resulting in higher concentrations of PGF<sub>2α</sub> than in systemic circulation.  
+
During the latter stages of the luteal phase the corpus luteum begins to regress under the effect of PGF<sub>2α</sub>. Normally the concentrations of PGF<sub>2α</sub> in arterial blood is relatively low due to extensive metabolism via the lungs. However there is a large concentration gradient from the uterine vein to the ovarian artery resulting in higher concentrations of PGF<sub>2α</sub> than in systemic circulation. If a pregnancy is to remain viable then luteolysis needs to be avoided and this is achieved where concentrations of PGF<sub>2α</sub> remain below a threshold level allowing the corpus luteum to continue to secrete prostaglandin. There are two main factors involved in the regulation of uterine secretions of PGF<sub>2α</sub>; oxytocin secretions from the corpus luteum and molecules secreted by the developing embryo that facilitate the maternal recognition of pregnancy.
 
<br />
 
<br />
 
<br />
 
<br />
During the second half of the [[Oestrous_Cycle_-_Anatomy_%26_Physiology#Luteal_Phase|luteal phase]] of the reproductive cycle prostaglandins are synthesised. These prostaglandins are lipid soluable and are therefore able to diffuse through cells walls into the ovarian artery. The overall concentrations of prostaglandins within the blood are reasonably low as the hormone is broken down within the lungs.
+
Oxytocin secretion via the corpus luteum stimulates endometrial production of PGF<sub>2α</sub> and by the end of the luteal phase the concentration of oxytocin and the number of oxytocin recptors within the endometrium allow the production of enough PGF<sub>2α</sub> to breach the threshold level and cause luteolysis. During pregnancy the embryonically produced pregnancy recognition molecules inhibit the secretion of PGF<sub>2α</sub> from the endometrium ensuring that luteolysis cannot occur.
    
===Prostaglandin (PGE<sub>2</sub>)===
 
===Prostaglandin (PGE<sub>2</sub>)===
6,273

edits

Navigation menu